Antihypertensive drugs reduce noradrenaline-induced hypertrophy of cultured myocardial cells

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 3, 1996, Pages 323-326

  Lahteenmaki T A ^a   Sievi, E ^a   Vapaatalo, H ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FELODIPINE; METOPROLOL; NORADRENALIN; PRAZOSIN; PROPRANOLOL; PROTEIN; VERAPAMIL;

ANIMAL CELL; ARTICLE; CELL GROWTH; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; MUSCLE FIBER CULTURE; NEWBORN; NONHUMAN; PROTEIN CONTENT; PROTEIN SYNTHESIS; RAT;

EID: 0029975440     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb05926.x     Document Type: Article

References (26)

1. Cooper, G., Mercer, W. E., Hoober, J. K., Gordon, P. R., Kent, R. L., Lauva, I K., Marino, T. A. (1986) Load regulation of the properties of adult feline cardiocytes. The role of substrate adhesion. Circ. Res. 58: 692-705
2. Dahlöf, B. (1988) Factors involved in the pathogenesis of hypertensive cardiovascular hypertrophy. Drugs 35 (Suppl.5): 6-26
3. Dahlöf, B., Pennert, K., Hansson, L. (1992) Regression of left ventricular hypertrophy. A meta-analysis. Clin. Exp. Hypertens. A14: 173-180
4. Decker, R. S., Cook, M. G., Behnke-Barclay, M. M., Decker, M. L., Lesch, M., Samarel, A. M. (1993) Catecholamines modulate protein turnover in cultured, quiescent rabbit cardiac myocytes. Am. J. Physiol. 265: H329-H339
5. 1Adrenoceptor classification: sharpening Occam's razor. Trends Pharmacol. Sci. 15: 167-170
6. Henrich, C. J., Simpson, P. C. (1987) Activation of protein kinase C in hypertrophy of cultured rat heart myocytes. Circulation 76(Suppl. IV): 235
7. 1-adrenergic and muscarinic but not β-adrenergic receptors in rat myocardium. J. Cardiovasc. Pharmacol. 4: 515-520
8. Kihara, M., Utagawa, N., Mano, M., Nara, Y., Horie, R., Yamori, Y. (1985) Biochemical aspects of salt-induced, pressure-independent left ventricular hypertrophy in rats. Heart Vessels 1:212-215
9. 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. J. Biol. Chem. 268: 15374-15380
10. Ko, Y., Totzke, G., Graack, G. H., Heidgen, F. J., Meyer zu Brickwedde, M. K., Düsing, R., Vetter, H., Sachinidis, A. (1993) Action of dihydropyridine calcium antagonists on early growth response gene expression and cell growth in vascular smooth muscle cells. J. Hypertens. 11: 1171-1178
11. Laks, M. M., Morady, F., Swan, H. J. (1973) Myocardial hypertrophy produced by chronic infusion of subhypertensive doses of norepinephrine in the dog. Chest 64: 75-79
12. Marban, E., Koretsune, Y. (1990) Cell calcium, oncogenes and hypertrophy. Hypertension 15: 652-658
13. 1-Adrenergic Stimulation of rat myocardial cells increases protein synthesis. Am. J. Physiol. 251: H1076-H1084
14. Mervaala, E. M. A., Himberg, J.-J., Laakso, J., Tuomainen, P., Karppanen, H. (1992) Beneficial effects of a potassium and magnesium-enriched salt alternative. Hypertension 19: 535-540
15. Mervaala, E. M. A., Laakso, J., Karppanen, H. (1994a) Cardiovascular effects of felodipine are not antagonized by dietary salt. Eur. J. Pharmacol. 255: 73-79
16. Mervaala, E. M. A., Laakso, J., Vapaatalo, H., Karppanen, H. (1994b) Improvement of cardiovascular effects of metoprolol by replacement of common salt with a potassium-and magnesium-enriched salt alternative. Br. J. Pharmacol. 112: 640-648
17. Mervaala, E. M. A., Laakso, J., Vapaatalo, H., Karppanen, H (1994c) Effects of enalapril and hydroctilorothiazide on the salt-induced cardiac and renal hypertrophy in normotensive rats. Naunyn Schmiedebergs Arch. Pharmacol. 350: 416-425
18. Mervaala, E. M. A., Paakkari, I., Laakso, J., Nevala, R., Teräväinen, T.-L., Fyhrquist, F., Vapaatalo, H., Karppanen, H. (1994d) Replacement of salt by a novel potassium-and magnesium-enriched salt alternative improves the cardiovascular effects of ramipril. Br. J. Pharmacol. 111: 1189-1197
19. Messerli, F. H., Oren, S., Grossman, E. (1988) Left ventricular hypertrophy and antihypertensive therapy. Drugs 35(Suppl 5): 27-33
20. Monopoli, A., Ongini, E. (1994) Effects of antihypertensive drugs on cardiac hypertrophy. Pharmacol. Res. 29: 197-215
21. Re, R. N. (1987) Cellular mechanisms of growth in cardiovascular tissue. Am. J. Cardiol. 60: 104-109
22. Sadoshima, J., Izumo, S. (1993) Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT, receptor subtype. Circ. Res. 73: 413-423
23. Schelling, P., Fischer, H., Ganten, D. (1991) Angiotensin and cell growth: a link to cardiovascular hypertrophy? J. Hypertens, 9: 315
24. 1adrenergic response. J. Clin. Invest. 72: 732-738
25. 1 -adrenergic receptor interaction. Evidence for independent regulation of growth and beating. Circ. Res. 56: 884-894
26. Walle, T., Webb, J. G., Bagwell, E. E., Walle, U. K., Daniell, G. B., Gaffney, T. E. (1988) Stereoselective delivery and actions of 3-receptor antagonists. Biochem. Pharmacol, 37: 115-124